Page last updated: 2024-08-25

4-aminopyrimidine and Parasitemia

4-aminopyrimidine has been researched along with Parasitemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Calvet, CM; Choi, JY; de Mesquita, LB; de Souza Pereira, MC; Hirata, K; Lostracco-Johnson, S; McKerrow, JH; Meuser-Batista, M; Nogueira, A; Podust, LM; Roush, WR; Silva, TA; Siqueira-Neto, JL; Suzuki, B; Thomas, D	1

Other Studies

1 other study(ies) available for 4-aminopyrimidine and Parasitemia

Article	Year
4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection. PLoS neglected tropical diseases, 2017, Volume: 11, Issue:12 Topics: 14-alpha Demethylase Inhibitors; Animals; Chagas Disease; Disease Models, Animal; Drug Discovery; Female; Heart; Lead; Male; Mice; Mice, Inbred BALB C; Myocardium; Parasitemia; Pyrimidines; Sterol 14-Demethylase; Sterols; Trypanocidal Agents; Trypanosoma cruzi	2017

Article

Year

4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.

PLoS neglected tropical diseases, 2017, Volume: 11, Issue:12

Topics: 14-alpha Demethylase Inhibitors; Animals; Chagas Disease; Disease Models, Animal; Drug Discovery; Female; Heart; Lead; Male; Mice; Mice, Inbred BALB C; Myocardium; Parasitemia; Pyrimidines; Sterol 14-Demethylase; Sterols; Trypanocidal Agents; Trypanosoma cruzi

2017